Journal
NATURE REVIEWS NEUROLOGY
Volume 13, Issue 3, Pages 131-+Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrneurol.2017.11
Keywords
-
Categories
Funding
- NIH National Institute on Aging [AGO5131, U01 AG024904]
Ask authors/readers for more resources
A European working group has provided a new set of recommendations for the use of cerebrospinal fluid (CSF) biomarkers in the diagnostic evaluation of Alzheimer disease and mild cognitive impairment. These recommendations represent an important step towards the implementation of CSF biomarker tests in the clinic, but several challenges remain.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
